###begin article-title 0
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
Aspergillus antigen induces robust Th2 cytokine production, inflammation, airway hyperreactivity and fibrosis in the absence of MCP-1 or CCR2
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 308 312 <span type="species:ncbi:10090">mice</span>
###xml 586 590 <span type="species:ncbi:10090">mice</span>
Asthma is characterized by type 2 T-helper cell (Th2) inflammation, goblet cell hyperplasia, airway hyperreactivity, and airway fibrosis. Monocyte chemoattractant protein-1 (MCP-1 or CCL2) and its receptor, CCR2, have been shown to play important roles in the development of Th2 inflammation. CCR2-deficient mice have been found to have altered inflammatory and physiologic responses in some models of experimental allergic asthma, but the role of CCR2 in contributing to inflammation and airway hyperreactivity appears to vary considerably between models. Furthermore, MCP-1-deficient mice have not previously been studied in models of experimental allergic asthma.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 116 128 116 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 291 303 291 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 436 448 436 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 224 228 <span type="species:ncbi:10090">mice</span>
To test whether MCP-1 and CCR2 are each required for the development of experimental allergic asthma, we applied an Aspergillus antigen-induced model of Th2 cytokine-driven allergic asthma associated with airway fibrosis to mice deficient in either MCP-1 or CCR2. Previous studies with live Aspergillus conidia instilled into the lung revealed that MCP-1 and CCR2 play a role in anti-fungal responses; in contrast, we used a non-viable Aspergillus antigen preparation known to induce a robust eosinophilic inflammatory response.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 212 224 212 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 303 315 303 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 358 362 <span type="species:ncbi:10090">mice</span>
We found that wild-type C57BL/6 mice developed eosinophilic airway inflammation, goblet cell hyperplasia, airway hyperreactivity, elevations in serum IgE, and airway fibrosis in response to airway challenge with Aspergillus antigen. Surprisingly, mice deficient in either MCP-1 or CCR2 had responses to Aspergillus antigen similar to those seen in wild-type mice, including production of Th2 cytokines.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
We conclude that robust Th2-mediated lung pathology can occur even in the complete absence of MCP-1 or CCR2.
###end p 9
###begin title 10
Background
###end title 10
###begin p 11
###xml 228 229 228 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 230 231 230 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 257 258 257 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 429 430 429 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 194 199 <span type="species:ncbi:9606">human</span>
###xml 535 539 <span type="species:ncbi:10090">mice</span>
###xml 807 811 <span type="species:ncbi:10090">mice</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1046 1050 <span type="species:ncbi:10090">mice</span>
###xml 1186 1190 <span type="species:ncbi:10090">mice</span>
Monocyte chemoattractant protein-1 (MCP-1, also known as CCL2) and its receptor, CCR2, have been the focus of intense interest due to increasing awareness of their association with debilitating human diseases, including asthma [1-3] and pulmonary fibrosis [4-7]. Since MCP-1 attracts and activates a variety of cells, including monocytes, immature dendritic cells, basophils, natural killer cells, and a subset of T lymphocytes [8-17], MCP-1 may have multiple roles in the immune response. Models of Th1 or Th2 inflammation applied to mice deficient in either MCP-1 or CCR2 have clearly shown important roles for this chemokine and its receptor in the development of inflammation [18-24]. However, results obtained using allergen-induced models of asthma (ovalbumin and cockroach antigen) in CCR2-deficient mice are varied, showing either increased, decreased or unchanged Th2 inflammation and airway hyperreactivity (AHR) [25-27], possibly due to differences in the allergen models or strains of mice used. These experiments with CCR2-deficient mice do not directly address the role of MCP-1, which is just one of several MCP chemokines that can bind to CCR2. Although MCP-1-deficient mice have been reported to have defects in Th2 responses [18,19], the effects of MCP-1 deletion in allergen-induced allergic experimental asthma have not been previously reported.
###end p 11
###begin p 12
###xml 118 120 118 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 121 123 121 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 243 265 243 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus fumigatus </italic>
###xml 276 289 276 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. fumigatus </italic>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 81 86 <span type="species:ncbi:9606">human</span>
###xml 243 264 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 276 288 <span type="species:ncbi:5085">A. fumigatus</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 353 357 <span type="species:ncbi:10090">mice</span>
###xml 421 425 <span type="species:ncbi:10090">mice</span>
###xml 772 776 <span type="species:ncbi:10090">mice</span>
In addition to Th2 inflammation, airway fibrosis is another important feature of human asthma. Blease and colleagues [28,29] examined the contributions of MCP-1 and CCR2 to the development of fibrosis following intratracheal administration of Aspergillus fumigatus conidia to A. fumigatus sensitized mice. Airway fibrosis was significantly increased in mice treated with MCP-1 neutralizing antibody and in CCR2-deficient mice. However, these increases in fibrosis were seen in the setting of impaired clearance of conidia and a markedly increased neutrophilic inflammatory response, suggesting that the increased fibrosis might be attributable simply to an impaired antifungal response. Previous studies involving other models of allergic asthma applied to CCR2-deficient mice did not examine whether airway fibrosis occurred in these models or whether development of fibrosis was dependent on CCR2 expression [25-27]. Consequently, the role of MCP-1 and CCR2 in the development of allergen-induced lung fibrosis is not well established.
###end p 12
###begin p 13
###xml 270 282 270 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 225 229 <span type="species:ncbi:10090">mice</span>
In this study, we hypothesized that the effects of MCP-1 are mediated through CCR2 and that MCP-1 and CCR2 are independently required for the development of experimental allergic asthma. To test this hypothesis, we subjected mice deficient in either MCP-1 or CCR2 to an Aspergillus antigen model of Th2-cytokine-driven allergic asthma associated with significant airway fibrosis and measured pulmonary inflammation, cytokine production, AHR and fibrosis.
###end p 13
###begin title 14
Methods
###end title 14
###begin title 15
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 15
###begin p 16
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 23 27 23 27 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 31 36 31 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 36 40 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 46 48 46 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 58 62 58 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 66 70 66 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 70 74 70 74 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 375 381 375 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1 </italic>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2 </italic>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 124 128 <span type="species:ncbi:10090">Mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 465 469 <span type="species:ncbi:10090">mice</span>
Breeding pairs of Mcp-1+/+ and Mcp-1-/- mice [19] and Ccr2+/+ and Ccr2-/- mice [21] were generated as previously described. Mice were bred and maintained under specific pathogen-free conditions in the Laboratory Animal Resource Center at San Francisco General Hospital. All mice were backcrossed nine times with C57BL/6 mice (Jackson Laboratory, Bar Harbor, ME). Deletion of Mcp-1 or Ccr2 genes was confirmed by PCR. Similar numbers of male and female six-week-old mice were used for the study. The UCSF Institutional Animal Care and Use Committee approved all experimental protocols.
###end p 16
###begin title 17
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
Aspergillus Antigen Sensitization Protocol
###end title 17
###begin p 18
###xml 4 26 4 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus fumigatus </italic>
###xml 284 286 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 360 372 357 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 499 511 495 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 612 624 608 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 782 794 778 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 949 951 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 4 25 <span type="species:ncbi:5085">Aspergillus fumigatus</span>
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
###xml 150 155 <span type="species:ncbi:10090">mouse</span>
###xml 334 338 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
###xml 581 585 <span type="species:ncbi:10090">mice</span>
The Aspergillus fumigatus antigen preparation consisted of a mixture of culture filtrate (300 mug protein/mouse) and mycelial extract (80 mug protein/mouse) in PBS (Cellgro by Mediatech, Inc, Herndon, VA). Culture filtrates and mycelial extract were prepared as described previously [30]. For sensitization, anesthetized six-week old mice were given 50 mul of Aspergillus antigen intranasally five times at four-day intervals. Control mice were given 50 mul of PBS according to the same schedule as Aspergillus antigen-treated mice. All measurements and samples were obtained from mice four days after the final Aspergillus antigen administration, which was 20 days after the first challenge. Our group has previously found that airway reactivity measured four days after the final Aspergillus antigen challenge was similar to reactivity measured at earlier time points (on the same day as the final challenge or one day after the final challenge) [30].
###end p 18
###begin title 19
Determination of Airway Reactivity
###end title 19
###begin p 20
###xml 808 811 805 808 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 274 278 <span type="species:ncbi:10090">mice</span>
Mice were anesthetized and paralyzed by intraperitoneal injection of etomidate (28 mg/kg) (Bedford Laboratories, Bedford, OH) and pancuronium bromide (0.1 mg/kg) (Baxter Healthcare Corporation, Irvine, CA). A tracheal cannula was inserted via a midcervical incision and the mice were ventilated using a Harvard model 683 rodent ventilator (9 mul/g tidal volume, 150 breaths per minute) (Harvard Apparatus, Holliston, MA). Using a whole body plethysmograph, airflow resistance was calculated during baseline breathing and in response to serially increasing doses of intravenous acetylcholine chloride (0.032, 0.100, 0.316, 1.00, and 3.16 mug/gm body weight) (Sigma, St. Louis, MO). The log of the concentration of acetylcholine (mug/gm) required for a 200% increase in total lung resistance, designated log PC200, was reported.
###end p 20
###begin title 21
Bronchoalveolar Lavage (BAL)
###end title 21
###begin p 22
After completion of the airway physiology measurements, the lungs were lavaged five times with 0.8-ml aliquots of sterile PBS. The lavage fluid was pooled and centrifuged, and the cell pellet was treated with red-blood-cell lysing buffer (Sigma, Saint Louis, MO). After being washed, the samples were resuspended in PBS. Total leukocytes were counted using a hemacytometer. Differential cell counts were determined by cytocentrifugation and Diff-Quik staining (Dade Behring Inc., Newark, DE) followed by microscopic examination of at least 300 cells.
###end p 22
###begin title 23
Thoracic Lymph Node Isolation and Lung Histology
###end title 23
###begin p 24
###xml 57 69 57 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Thoracic lymph nodes were harvested from mice exposed to Aspergillus antigen. Lungs were then removed en bloc and the left mainstem bronchus was firmly sutured closed. The left lung was removed by cutting the left mainstem distal to the suture. It was then frozen in liquid nitrogen and stored at -70degreesC until processed for hydroxyproline content. The right lung was inflated to 20 cm water pressure with 10% neutral buffered formalin (VWR Scientific Products, West Chester, PA) and fixed in 10% formalin for more than 48 h. Fixed lungs were embedded in paraffin, sectioned at 5 mum thickness, and stained with either hematoxylin and eosin (H&E), periodic acid Schiff (PAS), or trichrome by the Pathology Department of San Francisco General Hospital using standard protocols. The proportion of peribronchial inflammatory cells that were eosinophils was determined by counting inflammatory cells surrounding airways with lumens of 100-200 mum (measured on the short axis) on H&E stained sections. We analyzed 500 total cells (100 cells from each of five airways) for each animal studied.
###end p 24
###begin title 25
Analysis of Cytokine Production by Cells
###end title 25
###begin p 26
To prepare single-cell suspensions for cytokine analyses, isolated lymph nodes were gently minced using a syringe plunger and cells were passed through 70-mum cell strainers. Red blood cells were removed by hypotonic lysis at room temperature. Lymph node cells were counted, centrifuged, and resuspended in RPMI medium 1640 (Cellgro by Mediatech, Inc, Herndon, VA) supplemented with FCS (10% vol/vol) (Hyclone, Logan, UT), penicillin (100 U/ml) (Cellgro by Mediatech, Inc, Herndon, VA), streptomycin (100 mug/ml) (Cellgro by Mediatech, Inc, Herndon, VA), phorbol 12 myristate 13-acetate (PMA) (25 ng/m) (Sigma, Saint Louis, MO), and ionomycin (1 mug/ml) (Sigma, Saint Louis, MO) to a final concentration of 5 million cells per ml. Cells were then aliquoted into 96-well plates and incubated at 37degreesC. After 40 h, cell supernatants were harvested and stored at -70degreesC until they were analyzed. ELISA for IL-4, -5, -13 and IFN-gamma was performed on stimulated lymph node cell supernatant per the manufacturer's protocols (R&D Systems, Minneapolis, MN).
###end p 26
###begin title 27
Determination of MCP-1
###end title 27
###begin p 28
###xml 113 125 113 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 169 181 169 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 216 228 216 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
For quantitation of MCP-1 levels in BAL fluid, C57BL/6 wild-type mice were treated with the previously described Aspergillus antigen protocol. Four days after the final Aspergillus antigen administration, lungs from Aspergillus antigen- and PBS-treated mice were lavaged two times with 0.6-ml aliquots of sterile PBS. The samples were centrifuged and the supernatants were collected and stored at -70degreesC until analysis. ELISA for MCP-1 was performed on cell-free BAL fluid per the manufacturer's protocol (R&D Systems, Minneapolis, MN).
###end p 28
###begin title 29
Measurement of Serum Total IgE Concentration
###end title 29
###begin p 30
###xml 65 77 65 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 251 256 <span type="species:ncbi:10090">mouse</span>
###xml 448 459 <span type="species:ncbi:3704">horseradish</span>
Sera were obtained from blood collected by cardiac puncture from Aspergillus antigen- or PBS-treated mice after airway responsiveness measurement. Serum total IgE concentration was determined by a sandwich ELISA using complementary antibody pairs for mouse IgE (clone R35-72 and R35-118) obtained from Pharmingen (Pharmingen, San Diego, CA) according to the manufacturer's instructions. Color development was achieved using streptavidin-conjugated horseradish peroxidase (Pharmingen, San Diego, CA) followed by addition of HRP substrate (ABTS, Sigma, Saint Louis, MO).
###end p 30
###begin title 31
Determination of Lung Hydroxyproline Content
###end title 31
###begin p 32
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
Lungs were analyzed for hydroxyproline content as previously described [31] with slight modification. Lungs were homogenized in distilled water and incubated with 50% trichloroacetic acid on ice for 20 min. Samples were centrifuged and the pellet was mixed with 12 N hydrochloric acid and baked at 110degreesC for 14-18 h until samples were charred and dry. The samples were resuspended in 2 ml deionized water by incubating for 72 h at room temperature applying intermittent vortexing. Serial dilutions of trans-4-hydroxy-L-proline standard (Sigma, Saint Louis, MO) were prepared. 200 mul of vortexed sample (or standard) was added to 500 mul 1.4% chloramine T/0.5 M sodium acetate/10% isopropanol (Fisher Scientific, Pittsburgh, PA) and incubated for 20 min at room temperature. Next, 500 mul of Ehrlich's solution (1.0 M p-dimethylaminobenzaldehyde, 70% isopropanol/30% perchloric acid) (Fisher Scientific, Pittsburgh, PA) was added, mixed, and incubated at 65degreesC for 15 min. After samples returned to room temperature, the optical density of each sample and standard was measured at 550 nm and the concentration of lung hydroxyproline was calculated from the hydroxyproline standard curve.
###end p 32
###begin title 33
Statistical Analysis
###end title 33
###begin p 34
###xml 300 302 300 302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
Statistical significance for treatment effect was determined by analysis of variance with post-ANOVA t tests corrected for multiple comparisons using Bonferroni adjustment. These statistical analyses were performed using statistical software STATA 5.0 (Stata Corporation, College Station, TX) and R [32] (The R Foundation for Statistical Computing, Vienna, Austria). All tests were two-tailed with a p-value of 0.05 for statistical significance.
###end p 34
###begin title 35
Results
###end title 35
###begin title 36
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
Aspergillus antigen airway challenge induces MCP-1 production
###end title 36
###begin p 37
###xml 73 85 73 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 316 328 316 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 404 408 <span type="species:ncbi:10090">mice</span>
We used a model system that involved repeated intranasal challenges with Aspergillus antigen over a 20-day period. To determine whether antigen challenge induces MCP-1 production in the airway, we measured MCP-1 protein levels in BAL fluid from wild-type C57BL/6 mice on day 20. MCP-1 levels were markedly higher in Aspergillus antigen-treated mice (46.3 +/- 12.7 pg/ml, mean +/- SE) than in PBS-treated mice (5.8 +/- 1.3 pg/ml), (P = 0.01).
###end p 37
###begin title 38
###xml 74 86 74 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
MCP-1- and CCR2-deficient mice develop airway inflammation in response to Aspergillus antigen
###end title 38
###begin p 39
###xml 4 16 4 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 180 192 180 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 400 402 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 174 178 <span type="species:ncbi:10090">mice</span>
The Aspergillus antigen induction of MCP-1 was accompanied by a significant degree of lung inflammation as assessed by BAL fluid cell counts and lung histology. In wild-type mice, Aspergillus antigen induced a >20-fold increase in BAL fluid cell numbers (Fig. 1) and the development of prominent infiltrates in peribronchovascular spaces and scattered infiltrates in the lung parenchyma (Fig. 2A and 2B). The inflammatory infiltrates consisted of numerous eosinophils as well as other cell types.
###end p 39
###begin p 40
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 112 0 112 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen induced similar increases in BAL fluid cell counts in wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice. </bold>
###xml 240 245 238 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 245 249 243 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 253 257 251 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 257 261 255 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 298 310 296 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 345 357 343 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 261 265 <span type="species:ncbi:10090">mice</span>
###xml 286 290 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen induced similar increases in BAL fluid cell counts in wild-type, Mcp-1-/- and Ccr2-/- mice. Total cells, macrophages, eosinophils, and lymphocytes are expressed as mean BAL fluid total cell counts +/- SE from wild-type, Mcp-1-/- and Ccr2-/- mice (PBS-treated, N = 5 mice/group; Aspergillus antigen-treated, N = 8 mice/group; Aspergillus antigen exposure and sample collection are described in methods). Neutrophils represented <0.5% of total cells for all groups. The data shown are from one experiment and representative of three separate experiments. Asterisks (*) indicate values that are statistically significantly different (p < 0.001) compared to PBS controls.
###end p 40
###begin p 41
###xml 49 61 49 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 492 504 492 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 562 574 562 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 823 835 823 835 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 872 873 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1064 1065 1064 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 1399 1411 1391 1403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 124 128 <span type="species:ncbi:10090">mice</span>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 939 943 <span type="species:ncbi:10090">mice</span>
###xml 993 997 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1250 1254 <span type="species:ncbi:10090">mice</span>
###xml 1288 1292 <span type="species:ncbi:10090">mice</span>
###xml 1313 1317 <span type="species:ncbi:10090">mice</span>
To determine the airway inflammatory response to Aspergillus antigen in the absence of MCP-1 or its receptor, CCR2, we used mice with targeted disruptions of the genes that encode MCP-1 and CCR2. Since mouse strain differences are associated with major differences in antigen reactivity in many model systems, the mice used here were produced by extensive backcrossing into a C57BL/6 genetic background. Both MCP-1- and CCR2-deficient mice developed marked airway inflammation in response to Aspergillus antigen (Figs. 2C and 2D). The BAL fluid cell counts from Aspergillus antigen-treated MCP-1- and CCR2-deficient mice revealed significantly greater numbers of all cell types than in PBS-treated controls (p < 0.001). The numbers of macrophages, lymphocytes and neutrophils were not significantly different from those in Aspergillus antigen-treated wild-type mice (Fig. 1). The BAL fluid eosinophil response in MCP-1- and CCR2-deficient mice was slightly (~30-40%) smaller than in wild-type mice, but this difference did not reach statistical significance (Fig. 1). The fraction of peribronchial inflammatory cells that were eosinophils was not significantly different among wild-type mice (51 +/- 13%, mean +/- standard deviation), CCR2-deficient mice (52 +/- 6%), and MCP-1-deficient mice (37 +/- 13%) (N = 5 mice/group). These findings indicate that there was a robust inflammatory response to Aspergillus antigen even in the absence of MCP-1 or CCR2.
###end p 41
###begin p 42
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 76 81 76 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 93 97 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 103 0 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen-induced lung inflammation appears similar in wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice. </bold>
###xml 142 154 142 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 186 190 186 190 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 198 202 198 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 292 297 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 297 301 297 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 309 313 309 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 376 388 376 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 419 424 419 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 424 428 424 428 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 440 444 440 444 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 520 532 520 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 321 325 <span type="species:ncbi:10090">mice</span>
###xml 444 448 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen-induced lung inflammation appears similar in wild-type, Mcp-1-/- and Ccr2-/- mice. H&E stained lung sections from PBS- or Aspergillus antigen-treated wild-type, Mcp-1-/- and Ccr2-/- mice. Representative normal airway from wild-type control mice (A) (similar findings from Mcp-1-/- and Ccr2-/- control mice are not shown). Representative lung sections from Aspergillus antigen-treated wild-type (B), Mcp-1-/- (C) and Ccr2-/- mice (D) demonstrate intense peribronchiolar and perivascular inflammation. Aspergillus antigen exposure and sample collection are described in methods. Magnification: 20x objective.
###end p 42
###begin title 43
###xml 76 88 76 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
MCP-1- and CCR2-deficient mice develop AHR and produce mucus in response to Aspergillus antigen
###end title 43
###begin p 44
###xml 67 79 67 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 156 167 156 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 462 467 462 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 467 470 467 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 476 480 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 480 484 480 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 583 588 583 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 588 591 588 591 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 597 601 597 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 601 605 601 605 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 623 634 623 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 680 684 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 720 724 720 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200 </sub>
###xml 814 815 814 815 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 889 900 889 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 917 922 917 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 922 926 922 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 930 934 930 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 934 938 934 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 951 962 951 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 1079 1090 1079 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 1156 1161 1156 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 1161 1165 1161 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1168 1172 1168 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 1172 1176 1172 1176 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 51 55 <span type="species:ncbi:10090">mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 484 488 <span type="species:ncbi:10090">mice</span>
###xml 605 609 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
###xml 938 942 <span type="species:ncbi:10090">mice</span>
###xml 989 993 <span type="species:ncbi:10090">mice</span>
###xml 1141 1145 <span type="species:ncbi:10090">mice</span>
###xml 1176 1180 <span type="species:ncbi:10090">mice</span>
To determine airway reactivity to acetylcholine in mice exposed to Aspergillus antigen or to vehicle (PBS) alone, we compared airway reactivity of PBS- and Aspergillus-antigen-treated mice 4 days after the final challenge as described in the methods section. Measurements from this time point were previously found to be comparable to those from earlier time points [30]. In the experiment shown in Fig. 3, the PBS-treated group included a mixture of wild-type, Mcp-1-/-, and Ccr2-/- mice since preliminary experiments showed similar airway reactivity between PBS-treated wild-type, Mcp-1-/-, and Ccr2-/- mice (not shown). Aspergillus-antigen-treated wild-type, Mcp-1-/-, and Ccr2-/- mice each had significantly lower PC200 values than did PBS-treated controls (P < 0.001), indicating the development of AHR (Fig. 3). Although there appeared to be a trend toward less airway reactivity in Aspergillus-antigen-treated Mcp-1-/- and Ccr2-/- mice than in Aspergillus-antigen-treated wild-type mice, this trend was not statistically significant and was not observed in two additional Aspergillus-antigen-challenge experiments comparing wild-type mice to either Mcp-1-/- or Ccr2-/- mice separately (data not shown).
###end p 44
###begin p 45
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 51 55 51 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 63 67 63 67 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen induced AHR in wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice. </bold>
###xml 185 189 185 189 <sub xmlns:xlink="http://www.w3.org/1999/xlink">200 </sub>
###xml 239 251 239 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 356 368 356 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 67 71 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen induced AHR in wild-type, Mcp-1-/- and Ccr2-/- mice. Airway reactivity in response to intravenous acetylcholine was measured invasively. Data are expressed as log PC200 and lower values indicate higher airway response. Aspergillus antigen exposure and the airway measurement protocol are described in methods (PBS-treated, N = 12 mice; Aspergillus antigen-treated, N = 8-10 mice/group;). The data shown are from one experiment and representative of three separate experiments. Asterisks (*) indicate values that are statistically significantly different (p < 0.001) compared to PBS controls.
###end p 45
###begin p 46
###xml 16 27 16 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 146 148 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 236 247 236 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
###xml 364 366 364 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 367 369 367 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
###xml 388 400 388 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 500 512 500 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 217 221 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
To determine if Aspergillus-antigen challenge results in increased mucus production, we analyzed lung histology by PAS-staining. As shown in Fig. 4A, there was minimal PAS staining in the airway epithelium of control mice. In contrast, Aspergillus-antigen-treated mice from all three groups showed accumulation of PAS-stained material in epithelial cells (Fig. 4B,4C,4D), indicating that Aspergillus antigen airway challenge resulted in mucus production by goblet cells. These findings indicate that Aspergillus antigen induces AHR and mucus production even in the absence of MCP-1 or CCR2.
###end p 46
###begin p 47
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 71 75 71 75 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 83 87 83 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen induced goblet cell hyperplasia in wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice. </bold>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 235 239 235 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 243 247 243 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 247 251 247 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 280 292 280 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 328 332 328 332 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 340 344 340 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 344 348 344 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 426 438 426 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 259 263 <span type="species:ncbi:10090">mice</span>
###xml 348 352 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen induced goblet cell hyperplasia in wild-type, Mcp-1-/- and Ccr2-/- mice. Representative PAS-stained lung sections from PBS-treated wild-type mice (A) showed minimal PAS-positive staining (similar findings from Mcp-1-/- and Ccr2-/- control mice are not shown). Aspergillus antigen-treated wild-type (B), Mcp-1-/- (C) and Ccr2-/- mice (D) showed magenta staining in epithelial cells, which represents mucus. Aspergillus antigen exposure and sample collection are described in methods. Magnification, 40x objective.
###end p 47
###begin title 48
###xml 46 58 46 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 85 90 85 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 90 94 90 94 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Th2 cytokine and IgE production is similar in Aspergillus antigen-treated wild-type, Mcp-1-/- and Ccr2-/- mice
###end title 48
###begin p 49
###xml 74 86 74 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 209 221 209 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 553 555 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 556 558 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 559 561 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 562 564 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
###xml 628 632 624 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 632 636 628 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 720 731 716 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 828 830 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5E</xref>
###xml 832 844 828 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 897 902 893 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 902 905 898 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 911 915 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 915 919 911 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 381 385 <span type="species:ncbi:10090">mice</span>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 542 546 <span type="species:ncbi:10090">mice</span>
###xml 636 640 <span type="species:ncbi:10090">mice</span>
###xml 748 752 <span type="species:ncbi:10090">mice</span>
###xml 765 769 <span type="species:ncbi:10090">mice</span>
###xml 919 923 <span type="species:ncbi:10090">mice</span>
###xml 952 956 <span type="species:ncbi:10090">mice</span>
To determine if deletion of MCP-1 or CCR2 alters the cytokine response to Aspergillus antigen, we assayed Th1 and Th2 cytokines in stimulated cell supernatants prepared from thoracic lymph nodes isolated from Aspergillus antigen-treated mice. (PBS-treated mice had much smaller thoracic lymph nodes and it was not possible to reliably obtain sufficient numbers of cells from these mice for comparison.) MCP-1- and CCR2-deficient mice had concentrations of the cytokines IL-4, IL-5, IL-13 and IFN-gamma generally similar to those in wild-type mice (Fig. 5A,5B,5C,5D). There was a trend toward lower IL-4 production in cells from Ccr2-/- mice, but this difference was not statistically significant. In addition, sera from Aspergillus-antigen-treated mice and control mice were assayed for serum total IgE levels. As shown in Fig. 5E, Aspergillus antigen induced increases in serum IgE in wild-type, Mcp-1-/-, and Ccr2-/- mice similar to those in control mice.
###end p 49
###begin p 50
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 56 60 56 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 131 0 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen-treated wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice demonstrated intact Th2 cytokine production and induction of IgE. </bold>
###xml 190 202 190 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 229 234 229 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 246 250 246 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 432 444 428 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 471 476 467 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 476 480 472 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 484 488 480 484 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 488 492 484 488 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 691 703 685 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 811 823 805 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 861 873 855 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 60 64 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">mice</span>
###xml 492 496 <span type="species:ncbi:10090">mice</span>
###xml 509 513 <span type="species:ncbi:10090">mice</span>
###xml 719 724 <span type="species:ncbi:10090">mouse</span>
###xml 799 803 <span type="species:ncbi:10090">mice</span>
###xml 848 852 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen-treated wild-type, Mcp-1-/- and Ccr2-/- mice demonstrated intact Th2 cytokine production and induction of IgE. For cytokine determination, draining lymph node cells from Aspergillus antigen-treated wild-type, Mcp-1-/- and Ccr2-/- mice were isolated and stimulated with PMA/ionomycin for 40 hr and cytokine levels for IL-4 (A), IL-5 (B), IL-13 (C), and IFN-gamma (D) were quantitated by ELISA. Serum IgE (E) from Aspergillus antigen-treated wild-type, Mcp-1-/- and Ccr2-/- mice and control mice were measured by ELISA. In (A-D), bars represent mean +/- SE; in (E), results are expressed as the common log of IgE concentration where each circle represents a single PBS- or Aspergillus antigen-treated mouse and horizontal lines represent the mean of each group (PBS-treated, N = 5 mice/group; Aspergillus antigen-treated, N = 8-9 mice/group). Aspergillus antigen exposure and sample collection are described in methods. Asterisks (*) indicate values that are statistically significantly different (p < 0.001) compared to PBS controls.
###end p 50
###begin title 51
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
Aspergillus antigen-induced lung fibrosis develops in the absence of MCP-1 or CCR2
###end title 51
###begin p 52
###xml 21 33 21 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 159 170 159 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 201 202 201 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 205 217 205 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 370 373 370 373 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 379 383 379 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 383 387 383 387 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 528 530 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7A</xref>
###xml 570 582 570 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 672 674 672 674 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7B</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7C</xref>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7D</xref>
###xml 190 194 <span type="species:ncbi:10090">mice</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
###xml 445 449 <span type="species:ncbi:10090">mice</span>
###xml 552 556 <span type="species:ncbi:10090">mice</span>
###xml 753 757 <span type="species:ncbi:10090">mice</span>
###xml 805 809 <span type="species:ncbi:10090">mice</span>
To determine whether Aspergillus antigen-induced airway fibrosis develops in the absence of MCP-1 or CCR2, we measured lung hydroxyproline content in PBS- and Aspergillus-antigen-challenged mice (Fig. 6). Aspergillus antigen treatment resulted in a two-fold increase in lung hydroxyproline, a measure of collagen content. This effect was very similar in wild-type, Mcp-1-/-, and Ccr2-/- mice. Histopathologically, lung sections from PBS-treated mice had normal lung architecture and minimal evidence of trichrome staining (Fig. 7A). Lung sections from mice treated with Aspergillus antigen had clear increases in trichrome staining in a peribronchiolar distribution (Fig. 7B,7C,7D). There were no apparent differences in trichrome staining in wild-type mice as compared to either MCP-1- or CCR2-deficient mice after allergen challenge.
###end p 52
###begin p 53
###xml 0 12 0 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 64 69 64 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 91 0 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Aspergillus </italic>antigen induced similar lung fibrosis in wild-type, <italic>Mcp-1</italic><sup>-/- </sup>and <italic>Ccr2</italic><sup>-/- </sup>mice. </bold>
###xml 107 119 107 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 154 159 154 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 159 163 159 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 171 175 171 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 310 322 308 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 85 89 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
Aspergillus antigen induced similar lung fibrosis in wild-type, Mcp-1-/- and Ccr2-/- mice. Left lungs from Aspergillus antigen- or PBS-treated wild-type, Mcp-1-/- and Ccr2-/- mice were analyzed for total hydroxyproline content as described in methods. Results are expressed as mean +/- SE (N = 10 mice/group). Aspergillus antigen exposure and sample collection are described in methods; data are representative of two separate experiments. Asterisks (*) indicate values that are statistically significantly different (p < 0.001) compared to PBS controls.
###end p 53
###begin p 54
###xml 72 84 72 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Increased airway subepithelial collagen deposition after treatment with <italic>Aspergillus </italic>antigen. </bold>
###xml 224 229 224 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 229 233 229 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 241 245 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 336 348 336 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 379 384 379 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mcp-1</italic>
###xml 384 388 384 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ccr2</italic>
###xml 400 404 400 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 464 476 464 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 139 143 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
Increased airway subepithelial collagen deposition after treatment with Aspergillus antigen. Representative lung sections from PBS-treated mice show minimal trichrome staining around small airways (A) (similar findings from Mcp-1-/- and Ccr2-/- control mice are not shown). Increased trichrome staining is noted around small airways in Aspergillus antigen-treated wild-type (B), Mcp-1-/- (C) and Ccr2-/- (D) mice. Blue staining around airways represents collagen. Aspergillus antigen exposure and sample collection are described in methods. Magnification, 20x objective.
###end p 54
###begin title 55
Discussion
###end title 55
###begin p 56
###xml 101 112 101 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 199 211 199 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 660 672 660 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 464 468 <span type="species:ncbi:10090">mice</span>
We hypothesized that MCP-1 and its receptor, CCR2, are independently required for the development of Aspergillus-antigen-induced allergic asthma. We found that wild-type C57BL/6 mice challenged with Aspergillus antigen developed robust Th2 responses associated with pulmonary inflammation, AHR, mucus production and fibrosis. Surprisingly, neither MCP-1 nor CCR2 was critical for the development of these lung pathologies, since robust responses were also seen in mice with deletions of genes encoding either protein. These results demonstrate that neither MCP-1 nor CCR2 are required for the development of experimental allergic asthma induced by exposure to Aspergillus antigen.
###end p 56
###begin p 57
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 392 403 392 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus</italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 611 613 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 640 642 640 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 851 853 851 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 854 856 854 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 1106 1118 1106 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 1186 1193 1186 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 1402 1404 1402 1404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1555 1557 1555 1557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 1691 1693 1691 1693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 1808 1810 1808 1810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 1811 1813 1811 1813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2080 2087 2080 2087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al. </italic>
###xml 2088 2090 2088 2090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 435 441 <span type="species:ncbi:9606">people</span>
###xml 749 753 <span type="species:ncbi:10090">mice</span>
###xml 1031 1035 <span type="species:ncbi:10090">mice</span>
###xml 1306 1310 <span type="species:ncbi:10090">mice</span>
###xml 1618 1623 <span type="species:ncbi:10090">mouse</span>
###xml 1758 1762 <span type="species:ncbi:10090">mice</span>
###xml 1773 1777 <span type="species:ncbi:10090">mice</span>
###xml 1832 1836 <span type="species:ncbi:10090">mice</span>
###xml 2178 2182 <span type="species:ncbi:10090">mice</span>
###xml 2242 2246 <span type="species:ncbi:10090">mice</span>
Our results stand in contrast to some previous reports showing important roles for MCP-1 or CCR2 in other models of allergic asthma [25,27,33]. Although the precise explanation of these differences is not clear, there are several experimental factors that may contribute. For example, the choice of antigen and the route of sensitization differ between models. We used antigens prepared from Aspergillus, an important allergen in some people with asthma, and administered it exclusively to the respiratory tract, presumably a relevant route for sensitization in asthma. Previous studies have used ovalbumin [25,26,33] or cockroach antigen [27] and have used intraperitoneal antigen injections to sensitize prior to antigen challenge. CCR2-deficient mice have been shown to have defects in recruitment of antigen-presenting cells to the peritoneum [21,34,35], suggesting that CCR2 could be important for sensitization when antigen is administered to the peritoneum. Another factor that differs between studies is timing. We studied mice at 4 days after the final allergen challenge, when all aspects of the Aspergillus antigen-induced experimental asthma phenotype are present. Campbell et al. found that the administration of MCP-1 antibody could inhibit AHR in cockroach antigen sensitized and challenged mice at very early time points (1 and 8 h post challenge) but not later (24 h after challenge) [27]. The effect on AHR at 1 and 8 h was ascribed to MCP-1's ability to activate mast cells, which are important in some asthma models but not in others [36]. Genetic background may also be an important factor, since mouse strains vary widely in their response to airway antigen challenge [37]. Previous experimental asthma studies involving CCR2-deficient mice have used mice of mixed genetic backgrounds [25-27], whereas we used mice that had been backcrossed nine times to C57BL/6 and therefore have a more homogenous genetic background. Some of the specifics of our experimental system may therefore account for the lack of a requirement for MCP-1 and CCR2. However, MacLean et al. [26] used an allergic asthma model involving ovalbumin, intraperitoneal sensitization, and mice of mixed genetic backgrounds and found that CCR2-deficient mice had intact responses to allergen challenge. This indicates that the lack of a requirement for CCR2 is not unique to a single asthma model. It also highlights the difficulty in pinpointing the experimental factors that account for the diverse results reported by various investigators.
###end p 57
###begin p 58
###xml 96 108 96 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 141 153 141 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 372 403 372 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharopolyspora rectivirgula </italic>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 456 464 456 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 685 697 685 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 904 916 904 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 1048 1060 1048 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 1591 1593 1591 1593 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1707 1719 1707 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 283 287 <span type="species:ncbi:10090">mice</span>
###xml 372 402 <span type="species:ncbi:28042">Saccharopolyspora rectivirgula</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 1157 1161 <span type="species:ncbi:10090">mice</span>
###xml 1224 1228 <span type="species:ncbi:10090">mice</span>
Of note, neither MCP-1 nor CCR2 was critical for inflammatory cell migration to the lungs after Aspergillus antigen challenge. We found that Aspergillus antigen-induced monocyte recruitment (as measured by counting BAL fluid macrophages) was intact in both MCP-1- and CCR2-deficient mice. While intact alveolar macrophage recruitment in response to airway instillation of Saccharopolyspora rectivirgula has been reported in CCR2-deficient mice [38], other in vivo models have demonstrated requirements for MCP-1 and CCR2 in monocyte/macrophage recruitment [19,39-42]. Our finding indicates that other chemoattractants are sufficient for maximal monocyte/macrophage recruitment in this Aspergillus antigen model. In support of this observation, a recent microarray-based analysis of gene expression changes in a similar asthma model found that 14 different chemokines (including MCP-1/JE) were induced by Aspergillus antigen challenge [43]. However, we did find that MCP-1 and CCR2 may have indirect effects on eosinophil recruitment in response to Aspergillus antigen. While there was marked eosinophil recruitment to the lungs in MCP-1- and CCR2-deficient mice, there was a trend toward fewer eosinophils than in wild-type mice. Since MCP-1 is not a chemoattractant for eosinophils (which lack CCR2), this trend suggests that MCP-1 may have indirect effects on eosinophil recruitment in this model. A more dramatic decrease of eosinophil recruitment has been seen following neutralization of MCP-1 in another model, but that effect was associated with other signs of impaired Th2 immunity [33]. Although there may be some role for MCP-1 and CCR2 in eosinophil recruitment, robust inflammatory responses to Aspergillus antigen occurred even in the complete absence of either of these molecules.
###end p 58
###begin p 59
###xml 100 112 100 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 252 254 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 399 401 399 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 414 416 414 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 659 661 659 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 89 93 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 928 932 <span type="species:ncbi:10090">mice</span>
In contrast to our results indicating a robust Th2 response in MCP-1- and CCR2-deficient mice after Aspergillus antigen challenge, diminished Th2 cytokine production has been reported in studies of MCP-1 neutralization or deletion in different models [19,20,33,44,45]. In studies involving CCR2-deficient mice, the results have been more heterogenous, suggesting that CCR2 deletion may increase [25,28], decrease [24], or have no effect on Th2 responses [26]. As mentioned previously, the explanation for these different Th2 responses in CCR2-deficient mice is not clear, and may suggest that complex pathways involving other CCR2 ligands or MCP-1 receptors [46] are operational in different models of inflammation. However, if these pathways exist and were important in the model we used, we would have expected to find that deletion of MCP-1 and CCR2 had different effects. Instead, we observed that MCP-1- and CCR2-deficient mice were similar in all respects, including cytokine production, IgE production, and AHR. Our results support the idea that the role of MCP-1 and CCR2 in the development of allergic responses may be dependent upon the experimental model used.
###end p 59
###begin p 60
###xml 238 250 238 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 418 430 418 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 678 680 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1124 1126 1124 1126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1379 1381 1379 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1890 1902 1890 1902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 185 189 <span type="species:ncbi:10090">mice</span>
###xml 212 216 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1118 1122 <span type="species:ncbi:10090">mice</span>
###xml 1237 1241 <span type="species:ncbi:10090">mice</span>
###xml 1844 1848 <span type="species:ncbi:10090">mice</span>
###xml 1942 1946 <span type="species:ncbi:10090">mice</span>
The role of MCP-1 and CCR2 in the development of allergen-induced airway fibrosis has not been extensively explored. Previous findings of increased pulmonary fibrosis in CCR2-deficient mice compared to wild-type mice after treatment with Aspergillus conidia were accompanied by neutrophilic inflammation and the inability of CCR2-deficient mice to clear the organism normally [28,29]. Consequently, the persistence of Aspergillus organisms in the airway may have altered the fibrotic response. Other studies involving different experimental systems have suggested that MCP-1 and CCR2 may directly or indirectly contribute to the development of fibrosis. Gharaee-Kermani et al. [47] found that MCP-1 directly induced increased production of collagen by cultured fibroblasts, although the role of CCR2 was not explored in that report. MCP-1 and CCR2 may also indirectly influence fibrosis via their effects on inflammatory cells. Previous studies showed that CCR2-deficient mice developed less pulmonary fibrosis in response to three different stimuli, including intratracheal bleomycin instillation, than did wild-type mice [48,49]; however, those studies did not test the requirement for MCP-1 in the development of fibrosis. In C57BL/6 mice, bleomycin induces a robust inflammatory response that consists of neutrophils and lymphocytes, with a smaller component of eosinophils [50], in contrast to our allergen model. Thus, it is possible that the relative abundance or types of recruited cells in response to a particular airway challenge greatly influence the character or extent of lung fibrosis mediated by MCP-1 or CCR2.. Therefore, based on these previously published results we might have expected MCP-1 and CCR2 to be critical to the development of allergen-mediated fibrosis. However, we found that MCP-1-deficient and CCR2-deficient mice each developed marked fibrosis following Aspergillus antigen challenge, similar to wild-type mice. Our result, in contrast to the reported requirement for CCR2 in the development of bleomycin-induced pulmonary fibrosis, suggests that different cell types and mediators may be operational in allergen-induced airway fibrosis than those observed in bleomycin-induced lung fibrosis.
###end p 60
###begin title 61
Conclusions
###end title 61
###begin p 62
###xml 213 225 213 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aspergillus </italic>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 435 437 435 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 889 894 <span type="species:ncbi:9606">human</span>
In conclusion, this study demonstrates that pulmonary inflammation, Th2 immune responses, Th2-mediated airway pathology, and lung fibrosis are remarkably intact despite the complete absence of MCP-1 or CCR2 in an Aspergillus antigen-driven model of allergic airway disease. Previous studies have demonstrated roles for MCP-1 and CCR2 in other models of inflammation and fibrosis, including different allergic airway disease models [25,27,33]. Those findings indicate that the role of MCP-1 and CCR2 in allergic responses and in fibrosis depends on the models used, although it is difficult to identify which experimental factors determine whether MCP-1 and CCR2 are required. Both MCP-1 and CCR2 may be good therapeutic targets for some diseases. However, the variable involvement of these potential targets in animal models indicates that it may be extremely challenging to predict which human diseases are most likely to benefit from this approach.
###end p 62
###begin title 63
Abbreviations
###end title 63
###begin p 64
AHR, airways hyperreactivity; BALF, bronchoalveolar lavage fluid.
###end p 64
###begin title 65
Authors' contributions
###end title 65
###begin p 66
###xml 133 138 <span type="species:ncbi:10090">mouse</span>
###xml 166 171 <span type="species:ncbi:10090">mouse</span>
###xml 274 279 <span type="species:ncbi:10090">mouse</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
LLK conceived of the experiment, carried out all experiments and prepared the manuscript. MWR assisted in collection and analysis of mouse samples. XLB performed all mouse airway measurements. SC and XH performed antigen challenge and assisted in collection and analysis of mouse samples. IFC and BJR provided the targeted knock-out mice, provided expert advice and interpretation of the study's results. DJE participated in the study's design, coordination and final revisions of the manuscript. All authors read and approved the final manuscript.
###end p 66
###begin title 67
Acknowledgements
###end title 67
###begin p 68
We thank Yee Hwa Yang for statistical assistance and Dean Sheppard for helpful comments.
###end p 68
###begin article-title 69
Increased expression of the monocyte chemoattractant protein-1 in bronchial tissue from asthmatic subjects
###end article-title 69
###begin article-title 70
###xml 94 102 <span type="species:ncbi:9606">patients</span>
Increased MCP-1, RANTES, and MIP-1alpha in bronchoalveolar lavage fluid of allergic asthmatic patients
###end article-title 70
###begin article-title 71
###xml 77 85 <span type="species:ncbi:9606">patients</span>
Characteristics of the Inflammatory response in bronchial lavage fluids from patients with status asthmaticus
###end article-title 71
###begin article-title 72
###xml 57 62 <span type="species:ncbi:9606">human</span>
Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis
###end article-title 72
###begin article-title 73
###xml 63 71 <span type="species:ncbi:9606">patients</span>
Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis
###end article-title 73
###begin article-title 74
Monocyte chemoattractant protein-1 in idiopathic pulmonary fibrosis and other interstitial lung diseases
###end article-title 74
###begin article-title 75
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Clinical significance of MCP-1 levels in BALF and serum in patients with interstitial lung diseases
###end article-title 75
###begin article-title 76
Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture
###end article-title 76
###begin article-title 77
###xml 102 107 <span type="species:ncbi:9606">human</span>
Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line
###end article-title 77
###begin article-title 78
###xml 44 49 <span type="species:ncbi:9606">human</span>
Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants
###end article-title 78
###begin article-title 79
Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant
###end article-title 79
###begin article-title 80
Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3
###end article-title 80
###begin article-title 81
Activation of NK cells by CC chemokines. Chemotaxis, Ca2+ mobilization, and enzyme release
###end article-title 81
###begin article-title 82
###xml 56 61 <span type="species:ncbi:9606">human</span>
Monocyte chemotactic protein 1 is a potent activator of human basophils
###end article-title 82
###begin article-title 83
###xml 86 91 <span type="species:ncbi:9606">human</span>
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils
###end article-title 83
###begin article-title 84
Monocyte chemotactic and activating factor is a potent histamine-releasing factor for basophils
###end article-title 84
###begin article-title 85
Differential CC chemokine-induced enhancement of T helper cell cytokine production
###end article-title 85
###begin article-title 86
Chemokines in allergic lung inflammation
###end article-title 86
###begin article-title 87
###xml 110 114 <span type="species:ncbi:10090">mice</span>
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
###end article-title 87
###begin article-title 88
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
###end article-title 88
###begin article-title 89
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice
###end article-title 89
###begin article-title 90
###xml 70 82 <span type="species:ncbi:89924">Cryptococcus</span>
###xml 70 93 <span type="species:ncbi:5207">Cryptococcus neoformans</span>
CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection
###end article-title 90
###begin article-title 91
Differential roles of CC chemokine ligand 2/monocyte chemotactic protein-1 and CCR2 in the development of T1 immunity
###end article-title 91
###begin article-title 92
Effect of C-C chemokine receptor 2 (CCR2) knockout on type-2 (schistosomal antigen-elicited) pulmonary granuloma formation: analysis of cellular recruitment and cytokine responses
###end article-title 92
###begin article-title 93
###xml 57 61 <span type="species:ncbi:10090">mice</span>
Enhanced airway Th2 response after allergen challenge in mice deficient in CC chemokine receptor-2 (CCR2)
###end article-title 93
###begin article-title 94
CC chemokine receptor-2 is not essential for the development of antigen-induced pulmonary eosinophilia and airway hyperresponsiveness
###end article-title 94
###begin article-title 95
###xml 123 127 <span type="species:ncbi:10090">mice</span>
Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells
###end article-title 95
###begin article-title 96
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Enhanced pulmonary allergic responses to Aspergillus in CCR2-/- mice
###end article-title 96
###begin article-title 97
###xml 43 49 <span type="species:ncbi:10090">murine</span>
Antifungal and airway remodeling roles for murine monocyte chemoattractant protein-1/CCL2 during pulmonary exposure to Asperigillus fumigatus conidia
###end article-title 97
###begin article-title 98
###xml 83 87 <span type="species:ncbi:10090">mice</span>
Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice
###end article-title 98
###begin article-title 99
Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma
###end article-title 99
###begin article-title 100
R: A language for data analysis and graphics
###end article-title 100
###begin article-title 101
The coordinated action of CC chemokines in the lung orchestrates allergic inflammation and airway hyperresponsiveness
###end article-title 101
###begin article-title 102
###xml 69 73 <span type="species:ncbi:10090">mice</span>
Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2
###end article-title 102
###begin article-title 103
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor
###end article-title 103
###begin article-title 104
###xml 102 106 <span type="species:ncbi:10090">mice</span>
Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice
###end article-title 104
###begin article-title 105
###xml 80 86 <span type="species:ncbi:10090">murine</span>
Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response
###end article-title 105
###begin article-title 106
Experimental hypersensitivity pneumonitis:role of MCP-1
###end article-title 106
###begin article-title 107
Monocytes are potent facilitators of alveolar neutrophil emigration during lung inflammation: role of the CCL2-CCR2 axis
###end article-title 107
###begin article-title 108
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens
###end article-title 108
###begin article-title 109
Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1
###end article-title 109
###begin article-title 110
###xml 100 115 <span type="species:ncbi:10090">transgenic mice</span>
Monocyte chemoattractant protein-1 is sufficient for the chemotaxis of monocytes and lymphocytes in transgenic mice but requires an additional stimulus for inflammatory activation
###end article-title 110
###begin article-title 111
Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis
###end article-title 111
###begin article-title 112
Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production
###end article-title 112
###begin article-title 113
Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses
###end article-title 113
###begin article-title 114
MCP-1-dependent signaling in CCR2(-/-)aortic smooth muscle cells
###end article-title 114
###begin article-title 115
Costimulation of fibroblast collagen and transforming growth factor beta1 gene expression by monocyte chemoattractant protein-1 via specific receptors
###end article-title 115
###begin article-title 116
Protection from pulmonary fibrosis in the absence of CCR2 signaling
###end article-title 116
###begin article-title 117
IL-13-induced chemokine responses in the lung: role of CCR2 in the pathogenesis of IL-13-induced inflammation and remodeling
###end article-title 117
###begin article-title 118
Bleomycin-induced pulmonary fibrosis is independent of eosinophils
###end article-title 118

